Jeffrey Zekauskas

Stock Analyst at JP Morgan

(3.92)
# 604
Out of 5,152 analysts
563
Total ratings
59.11%
Success rate
6.97%
Average return

Stocks Rated by Jeffrey Zekauskas

The Chemours Company
Feb 23, 2026
Maintains: Neutral
Price Target: $13$17
Current: $16.75
Upside: +1.49%
Nutrien
Feb 20, 2026
Maintains: Overweight
Price Target: $68$78
Current: $74.39
Upside: +4.85%
CF Industries Holdings
Feb 20, 2026
Maintains: Neutral
Price Target: $80$94
Current: $110.78
Upside: -15.15%
Celanese
Feb 19, 2026
Maintains: Neutral
Price Target: $40$53
Current: $52.55
Upside: +0.86%
Huntsman
Feb 19, 2026
Downgrades: Neutral
Price Target: $11$14
Current: $12.55
Upside: +11.55%
Valvoline
Feb 12, 2026
Downgrades: Underweight
Price Target: $30$35
Current: $36.06
Upside: -2.94%
Ecolab
Feb 11, 2026
Maintains: Neutral
Price Target: $265$295
Current: $286.93
Upside: +2.81%
Silgan Holdings
Feb 9, 2026
Maintains: Overweight
Price Target: $44$53
Current: $45.86
Upside: +15.57%
Avery Dennison
Feb 9, 2026
Maintains: Overweight
Price Target: $195$205
Current: $183.73
Upside: +11.58%
Linde
Feb 6, 2026
Downgrades: Neutral
Price Target: $455
Current: $490.06
Upside: -7.15%
Downgrades: Neutral
Price Target: $112$115
Current: $108.15
Upside: +6.33%
Downgrades: Neutral
Price Target: $75$77
Current: $76.59
Upside: +0.54%
Maintains: Overweight
Price Target: $77$70
Current: $57.37
Upside: +22.01%
Maintains: Neutral
Price Target: $50$60
Current: $63.22
Upside: -5.09%
Maintains: Neutral
Price Target: $260$280
Current: $276.35
Upside: +1.32%
Maintains: Neutral
Price Target: $23$26
Current: $33.72
Upside: -22.89%
Maintains: Overweight
Price Target: $117$126
Current: $111.87
Upside: +12.63%
Maintains: Neutral
Price Target: $80$195
Current: $163.93
Upside: +18.95%
Upgrades: Overweight
Price Target: $117$115
Current: $104.91
Upside: +9.62%
Maintains: Underweight
Price Target: $9$5
Current: $5.29
Upside: -5.48%
Maintains: Underweight
Price Target: $75$54
Current: $74.02
Upside: -27.05%
Maintains: Neutral
Price Target: $43$14
Current: $14.29
Upside: -2.03%
Maintains: Overweight
Price Target: $36$38
Current: $41.98
Upside: -9.48%
Maintains: Neutral
Price Target: $52$50
Current: $65.88
Upside: -24.10%
Upgrades: Overweight
Price Target: $33$38
Current: $57.05
Upside: -33.39%
Maintains: Neutral
Price Target: $30$29
Current: $30.26
Upside: -4.16%
Maintains: Overweight
Price Target: $378$385
Current: $335.45
Upside: +14.77%
Downgrades: Neutral
Price Target: n/a
Current: $7.28
Upside: -
Maintains: Neutral
Price Target: $73$78
Current: $105.51
Upside: -26.07%
Assumes: Overweight
Price Target: $56$50
Current: $43.69
Upside: +14.44%
Downgrades: Underweight
Price Target: $15$18
Current: $23.85
Upside: -24.53%
Maintains: Underweight
Price Target: $50$54
Current: $61.64
Upside: -12.39%
Maintains: Neutral
Price Target: $28$20
Current: $24.62
Upside: -18.77%
Maintains: Overweight
Price Target: $80$65
Current: $66.16
Upside: -1.75%
Maintains: Overweight
Price Target: $107$104
Current: $75.38
Upside: +37.97%
Maintains: Overweight
Price Target: $26$29
Current: $8.52
Upside: +240.38%
Maintains: Overweight
Price Target: $75$73
Current: $26.28
Upside: +177.78%
Upgrades: Overweight
Price Target: $80$75
Current: $70.16
Upside: +6.90%
Maintains: Overweight
Price Target: $68$70
Current: $72.18
Upside: -3.02%
Maintains: Overweight
Price Target: $92$110
Current: $159.99
Upside: -31.25%